Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation.

Uffing A, Hidalgo LG, McMullan C, Perry J, Milford EL, Murakami N, Yeung MY, Guleria I, Wood IG, Akalin E, Azzi J, Chandraker AK, Riella LV.

Transplant Direct. 2019 Apr 15;5(5):e446. doi: 10.1097/TXD.0000000000000893. eCollection 2019 May.

2.

Patient and Clinician Perspectives on Electronic Patient-Reported Outcome Measures in the Management of Advanced CKD: A Qualitative Study.

Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Dutton M, Walmsley-Allen N, Slade A, McMullan C, Calvert M.

Am J Kidney Dis. 2019 Apr 16. pii: S0272-6386(19)30613-4. doi: 10.1053/j.ajkd.2019.02.011. [Epub ahead of print]

PMID:
31003865
3.

Evaluation of Allostatic Load as a Mediator of Sleep and Kidney Outcomes in Black Americans.

Lunyera J, Davenport CA, Jackson CL, Johnson DA, Bhavsar NA, Sims M, Scialla JJ, Stanifer JW, Pendergast J, McMullan CJ, Ricardo AC, Boulware LE, Diamantidis CJ.

Kidney Int Rep. 2018 Dec 18;4(3):425-433. doi: 10.1016/j.ekir.2018.12.005. eCollection 2019 Mar.

4.

Electronic patient reported outcomes to support care of patients with traumatic brain injury: PRiORiTy study qualitative protocol.

Retzer A, Turner GM, Slade A, Kyte D, McMullan C, Jones L, Belli A, Calvert M.

BMJ Open. 2019 Jan 25;9(1):e024617. doi: 10.1136/bmjopen-2018-024617.

5.

Facilitating Implementation of Research Evidence (FIRE): an international cluster randomised controlled trial to evaluate two models of facilitation informed by the Promoting Action on Research Implementation in Health Services (PARIHS) framework.

Seers K, Rycroft-Malone J, Cox K, Crichton N, Edwards RT, Eldh AC, Estabrooks CA, Harvey G, Hawkes C, Jones C, Kitson A, McCormack B, McMullan C, Mockford C, Niessen T, Slater P, Titchen A, van der Zijpp T, Wallin L.

Implement Sci. 2018 Nov 16;13(1):137. doi: 10.1186/s13012-018-0831-9.

6.

A realist process evaluation within the Facilitating Implementation of Research Evidence (FIRE) cluster randomised controlled international trial: an exemplar.

Rycroft-Malone J, Seers K, Eldh AC, Cox K, Crichton N, Harvey G, Hawkes C, Kitson A, McCormack B, McMullan C, Mockford C, Niessen T, Slater P, Titchen A, van der Zijpp T, Wallin L.

Implement Sci. 2018 Nov 16;13(1):138. doi: 10.1186/s13012-018-0811-0.

7.

Complements from the Lung.

Downing NS, McMullan CJ, Rennke HG, Levy BD, Loscalzo J.

N Engl J Med. 2018 Nov 1;379(18):1767-1773. doi: 10.1056/NEJMcps1802644. No abstract available.

PMID:
30380383
8.

An introduction to patient-reported outcome measures (PROMs) in trauma.

Turner GM, Slade A, Retzer A, McMullan C, Kyte D, Belli A, Calvert M.

J Trauma Acute Care Surg. 2019 Feb;86(2):314-320. doi: 10.1097/TA.0000000000002102.

PMID:
30376536
9.

Chronic Insufficient Sleep Has a Limited Impact on Circadian Rhythmicity of Subjective Hunger and Awakening Fasted Metabolic Hormones.

McHill AW, Hull JT, McMullan CJ, Klerman EB.

Front Endocrinol (Lausanne). 2018 Jun 12;9:319. doi: 10.3389/fendo.2018.00319. eCollection 2018.

10.

Establishing research priorities relating to the long-term impact of TIA and minor stroke through stakeholder-centred consensus.

Turner GM, Backman R, McMullan C, Mathers J, Marshall T, Calvert M.

Res Involv Engagem. 2018 Jan 25;4:2. doi: 10.1186/s40900-018-0089-z. eCollection 2018.

11.

Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.

Srivastava A, Kaze AD, McMullan CJ, Isakova T, Waikar SS.

Am J Kidney Dis. 2018 Mar;71(3):362-370. doi: 10.1053/j.ajkd.2017.08.017. Epub 2017 Nov 11.

12.

A mixed-methods feasibility and external pilot study to inform a large pragmatic randomised controlled trial of the effects of surgical wound dressing strategies on surgical site infections (Bluebelle Phase B): study protocol for a randomised controlled trial.

Bluebelle Study Group, Reeves BC, Andronis L, Blazeby JM, Blencowe NS, Calvert M, Coast J, Draycott T, Donovan JL, Gooberman-Hill R, Longman RJ, Magill L, Mathers JM, Pinkney TD, Rogers CA, Rooshenas L, Torrance A, Welton NJ, Woodward M, Ashton K, Bera KD, Clayton GL, Culliford LA, Dumville JC, Elliott D, Ellis L, Gould-Brown H, Macefield RC, McMullan C, Pope C, Siassakos D, Strong S, Talbot H.

Trials. 2017 Aug 29;18(1):401. doi: 10.1186/s13063-017-2102-5.

13.

Adapting to ulcerative colitis to try to live a 'normal' life: a qualitative study of patients' experiences in the Midlands region of England.

McMullan C, Pinkney TD, Jones LL, Magill L, Nepogodiev D, Pathmakanthan S, Cooney R, Mathers JM.

BMJ Open. 2017 Aug 21;7(8):e017544. doi: 10.1136/bmjopen-2017-017544.

14.

CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.

Mallat SG, Tanios BY, Itani HS, Lotfi T, McMullan C, Gabardi S, Akl EA, Azzi JR.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1321-1336. doi: 10.2215/CJN.13221216. Epub 2017 Jun 2. Review.

15.

Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.

McMullan CJ, Borgi L, Fisher N, Curhan G, Forman J.

Clin J Am Soc Nephrol. 2017 May 8;12(5):807-816. doi: 10.2215/CJN.10771016. Epub 2017 Mar 20.

16.

Effect of Vitamin D on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial.

Borgi L, McMullan C, Wohlhueter A, Curhan GC, Fisher ND, Forman JP.

Am J Hypertens. 2017 Feb;30(2):124-129. doi: 10.1093/ajh/hpw135. Epub 2016 Nov 15. Erratum in: Am J Hypertens. 2017 Jul 1;30(7):731.

17.

The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial.

McMullan CJ, Borgi L, Curhan GC, Fisher N, Forman JP.

J Hypertens. 2017 Apr;35(4):822-829. doi: 10.1097/HJH.0000000000001220.

18.

Effect of Uric Acid-Lowering Agents on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial.

Borgi L, McMullan C, Wohlhueter A, Curhan GC, Fisher ND, Forman JP.

Hypertension. 2017 Feb;69(2):243-248. doi: 10.1161/HYPERTENSIONAHA.116.08488. Epub 2016 Dec 27.

19.

A nested case-control study of the association between melatonin secretion and incident myocardial infarction.

McMullan CJ, Rimm EB, Schernhammer ES, Forman JP.

Heart. 2017 May;103(9):694-701. doi: 10.1136/heartjnl-2016-310098. Epub 2016 Nov 2.

PMID:
27806988
20.

Association of short sleep duration and rapid decline in renal function.

McMullan CJ, Curhan GC, Forman JP.

Kidney Int. 2016 Jun;89(6):1324-30. doi: 10.1016/j.kint.2015.12.048. Epub 2016 Mar 25.

21.

Risk assessment in acute non-variceal upper GI bleeding: the AIMS65 score in comparison with the Glasgow-Blatchford score in a Scottish population.

Palmer AJ, Moroni F, Mcleish S, Campbell G, Bardgett J, Round J, McMullan C, Rashid M, Clark R, De Las Heras D, Vincent C.

Frontline Gastroenterol. 2016 Apr;7(2):90-96. doi: 10.1136/flgastro-2015-100594. Epub 2015 Jun 5.

22.

Finding a Signal in the Noise.

McMullan CJ, Forman JP.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):374-6. doi: 10.2215/CJN.00880116. Epub 2016 Feb 18. No abstract available.

23.

A Bridge Over Turbulent Waters: Illustrating the Interaction Between Managerial Leaders and Facilitators When Implementing Research Evidence.

van der Zijpp TJ, Niessen T, Eldh AC, Hawkes C, McMullan C, Mockford C, Wallin L, McCormack B, Rycroft-Malone J, Seers K.

Worldviews Evid Based Nurs. 2016 Feb;13(1):25-31. doi: 10.1111/wvn.12138. Epub 2016 Jan 20.

PMID:
26788694
24.

Do industrial incidents in the chemical sector create equity market contagion?

Brown GD, Corbet S, McMullan C, Sharma R.

J Safety Res. 2015 Dec;55:115-9. doi: 10.1016/j.jsr.2015.08.009. Epub 2015 Sep 13.

PMID:
26683554
25.

Preparing to respond: Irish nurses' perceptions of preparedness for an influenza pandemic.

McMullan C, Brown GD, O'Sullivan D.

Int Emerg Nurs. 2016 May;26:3-7. doi: 10.1016/j.ienj.2015.10.004. Epub 2015 Nov 17.

PMID:
26597971
26.

Reasons for non-participation in the Northern Ireland Bowel Cancer Screening Programme: a qualitative study.

Bradley DT, Treanor C, McMullan C, Owen T, Graham A, Anderson D.

BMJ Open. 2015 Sep 9;5(9):e008266. doi: 10.1136/bmjopen-2015-008266.

27.

'I have the world's best job' - staff experience of the advantages of caring for older people.

Eldh AC, van der Zijpp T, McMullan C, McCormack B, Seers K, Rycroft-Malone J.

Scand J Caring Sci. 2016 Jun;30(2):365-73. doi: 10.1111/scs.12256. Epub 2015 Aug 12.

PMID:
26265314
28.

Prospective analysis of the association of ambulatory blood pressure characteristics with incident chronic kidney disease.

McMullan CJ, Hickson DA, Taylor HA, Forman JP.

J Hypertens. 2015 Sep;33(9):1939-46; discussion 1946. doi: 10.1097/HJH.0000000000000638.

PMID:
26066645
29.

Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease.

McMullan CJ, Yano Y, Bakris GL, Kario K, Phillips RA, Forman JP.

J Am Soc Hypertens. 2015 Apr;9(4):299-306. doi: 10.1016/j.jash.2015.02.005. Epub 2015 Feb 12.

PMID:
25891362
30.

Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.

McMullan CJ, Lambers Heerspink HJ, Parving HH, Dwyer JP, Forman JP, de Zeeuw D.

Am J Kidney Dis. 2014 Nov;64(5):714-22. doi: 10.1053/j.ajkd.2014.06.008. Epub 2014 Jul 24.

PMID:
25064674
31.

Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.

Neilan TG, Mongeon FP, Shah RV, Coelho-Filho O, Abbasi SA, Dodson JA, McMullan CJ, Heydari B, Michaud GF, John RM, Blankstein R, Jerosch-Herold M, Kwong RY.

JACC Cardiovasc Imaging. 2014 Jan;7(1):1-11. doi: 10.1016/j.jcmg.2013.08.013. Epub 2013 Nov 27.

32.

The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation .

Neilan TG, Shah RV, Abbasi SA, Farhad H, Groarke JD, Dodson JA, Coelho-Filho O, McMullan CJ, Heydari B, Michaud GF, John RM, van der Geest R, Steigner ML, Blankstein R, Jerosch-Herold M, Kwong RY.

J Am Coll Cardiol. 2013 Dec 10;62(23):2205-14. doi: 10.1016/j.jacc.2013.07.067. Epub 2013 Aug 28.

33.

Melatonin level and risk for type 2 diabetes--in reply.

McMullan CJ, Schernhammer ES, Forman JP.

JAMA. 2013 Aug 7;310(5):537. doi: 10.1001/jama.2013.7655. No abstract available.

PMID:
23925631
34.

Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women.

McMullan CJ, Curhan GC, Schernhammer ES, Forman JP.

Am J Epidemiol. 2013 Jul 15;178(2):231-8. doi: 10.1093/aje/kws470. Epub 2013 Jun 28.

35.

Melatonin secretion and the incidence of type 2 diabetes.

McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP.

JAMA. 2013 Apr 3;309(13):1388-96. doi: 10.1001/jama.2013.2710.

36.

Association of BP variability with mortality among African Americans with CKD.

McMullan CJ, Bakris GL, Phillips RA, Forman JP.

Clin J Am Soc Nephrol. 2013 May;8(5):731-8. doi: 10.2215/CJN.10131012. Epub 2013 Mar 14.

37.

Race, plasma renin activity, and morning blood pressure surge--results from the Dietary Approaches to Stop Hypertension trial.

Mc Causland FR, McMullan CJ, Sacks FM, Forman JP.

Am J Hypertens. 2014 Apr;27(4):530-6. doi: 10.1093/ajh/hpt031. Epub 2013 Mar 8.

38.

A multidisciplinary approach to reduce central line-associated bloodstream infections.

McMullan C, Propper G, Schuhmacher C, Sokoloff L, Harris D, Murphy P, Greene WH.

Jt Comm J Qual Patient Saf. 2013 Feb;39(2):61-9.

PMID:
23427477
39.

Preparing for the future: challenges and opportunities for management and leadership skills.

Morison S, McMullan C.

Br Dent J. 2013 Jan;214(1):E2. doi: 10.1038/sj.bdj.2012.1177.

PMID:
23306518
40.

Early warning systems: the next level of rapid response.

Duncan KD, McMullan C, Mills BM.

Nursing. 2012 Feb;42(2):38-44; quiz 45. doi: 10.1097/01.NURSE.0000410304.26165.33. No abstract available.

PMID:
22227597
41.

Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.

Poulaki V, Mitsiades CS, Kotoula V, Negri J, McMullan C, Miller JW, Marks PA, Mitsiades N.

Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4072-9. doi: 10.1167/iovs.09-3517. Epub 2009 Apr 22.

PMID:
19387079
42.

Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo.

Mitsiades CS, Ocio EM, Pandiella A, Maiso P, Gajate C, Garayoa M, Vilanova D, Montero JC, Mitsiades N, McMullan CJ, Munshi NC, Hideshima T, Chauhan D, Aviles P, Otero G, Faircloth G, Mateos MV, Richardson PG, Mollinedo F, San-Miguel JF, Anderson KC.

Cancer Res. 2008 Jul 1;68(13):5216-25. doi: 10.1158/0008-5472.CAN-07-5725.

43.

Significant reductions in methicillin-resistant Staphylococcus aureus bacteraemia and clinical isolates associated with a multisite, hand hygiene culture-change program and subsequent successful statewide roll-out.

Grayson ML, Jarvie LJ, Martin R, Johnson PD, Jodoin ME, McMullan C, Gregory RH, Bellis K, Cunnington K, Wilson FL, Quin D, Kelly AM; Hand Hygiene Study Group and Hand Hygiene Statewide Roll-out Group, Victorian Quality Council.

Med J Aust. 2008 Jun 2;188(11):633-40.

PMID:
18513171
44.

Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.

Mitsiades CS, Hayden P, Kotoula V, McMillin DW, McMullan C, Negri J, Delmore JE, Poulaki V, Mitsiades N.

J Clin Endocrinol Metab. 2007 Dec;92(12):4845-52. Epub 2007 Sep 11.

PMID:
17848408
45.

Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.

Mitsiades CS, Negri J, McMullan C, McMillin DW, Sozopoulos E, Fanourakis G, Voutsinas G, Tseleni-Balafouta S, Poulaki V, Batt D, Mitsiades N.

Mol Cancer Ther. 2007 Mar;6(3):1070-8.

46.

Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.

Mitsiades CS, McMillin D, Kotoula V, Poulaki V, McMullan C, Negri J, Fanourakis G, Tseleni-Balafouta S, Ain KB, Mitsiades N.

J Clin Endocrinol Metab. 2006 Oct;91(10):4013-21. Epub 2006 Jul 18.

PMID:
16849420
47.

Antimyeloma activity of heat shock protein-90 inhibition.

Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Kung AL, Davies FE, Morgan G, Akiyama M, Shringarpure R, Munshi NC, Richardson PG, Hideshima T, Chauhan D, Gu X, Bailey C, Joseph M, Libermann TA, Rosen NS, Anderson KC.

Blood. 2006 Feb 1;107(3):1092-100. Epub 2005 Oct 18.

48.

Novel histone deacetylase inhibitors in the treatment of thyroid cancer.

Mitsiades CS, Poulaki V, McMullan C, Negri J, Fanourakis G, Goudopoulou A, Richon VM, Marks PA, Mitsiades N.

Clin Cancer Res. 2005 May 15;11(10):3958-65.

49.

Healing in places of decline: (re)imagining everyday landscapes in Hamilton, Ontario.

Wakefield S, McMullan C.

Health Place. 2005 Dec;11(4):299-312.

PMID:
15886139
50.

Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.

Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J, Goudopoulou A, Halikias IX, Voutsinas G, Tseleni-Balafouta S, Miller JW, Mitsiades N.

Invest Ophthalmol Vis Sci. 2005 Jan;46(1):358-66.

PMID:
15623796

Supplemental Content

Loading ...
Support Center